Skip to main content

NU Researchers Receive Intramural Funding for the Study of Emerging and Re-emerging Infectious Diseases

The Emerging and Re-Emerging Pathogens Program (EREPP) in the Division of Infectious Diseases at FSM strives to foster research aimed at better understanding new infectious threats.  Congratulations to these investigators, who were awarded grants as part of the first EREPP Call for Proposals:

 

Pablo Penaloza-MacMaster, PhD

Judd Hultquist, PhD

Pablo Penaloza-MacMaster, PhD (Department of Microbiology-Immunology) and Judd Hultquist, PhD (Department of Medicine, Division of Infectious Diseases) for the study of “Elucidating immunological parameters associated with recovery from COVID-19 disease,” $50,000.

 

 

 


 

Huiping Liu, MD, PhD

Deyu Fang, PhD

Michael G. Ison, MD

Suchitra Swaminathan, PhD

 

 

 

 

 

 

 

 

Huiping Liu, MD, PhD (Department of Pharmacology), Deyu Fang, PhD (Department of Pathology), Michael Ison, MD (Department of Medicine, Division of Infectious Diseases), and Suchitra Swaminathan, PhD (Department of Medicine, Division of Rheumatology) for the study of “Generation of human monoclonal antibody neutralizing SARS-CoV-2 using patient B cells,” $50,000.

 


 

Chad Achenbach, MD

Chad Achenbach, MD (Department of Medicine, Division of Infectious Diseases) for the study of “COVID-19 presentation, testing, treatment and outcomes at Northwestern Medicine,” $30,000.

 

 

 


 

Eun-Young Kim, PhD

Steven Wolinsky, MD

Eun-Young Kim, PhD and Steven Wolinsky, MD (Department of Medicine, Division of Infectious Diseases) for the study of “Pathogenesis in the nonhuman primate model for SARS-CoV-2,” $40,000.

Leave a Comment

Your email address will not be published. Required fields are marked *